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Background: The phenylpropanoid metabolites are an extremely diverse group of natural products biosynthesized
by plants, fungi, and bacteria. Although these compounds are widely used in human health care and nutrition
services, their availability is limited by regional variations, and isolation of single compounds from plants is often
difficult. Recent advances in synthetic biology and metabolic engineering have enabled artificial production of plant
secondary metabolites in microorganisms.
Results: We develop an Escherichia coli system containing an artificial biosynthetic pathway that yields
phenylpropanoic acids, such as 4-coumaric acid, caffeic acid, and ferulic acid, from simple carbon sources. These
artificial biosynthetic pathways contained a codon-optimized tal gene that improved the productivity of 4-coumaric
acid and ferulic acid, but not caffeic acid in a minimal salt medium. These heterologous pathways extended in E.
coli that had biosynthesis machinery overproducing tyrosine. Finally, the titers of 4-coumaric acid, caffeic acid, and
ferulic acid reached 974 mg/L, 150 mg/L, and 196 mg/L, respectively, in shake flasks after 36-hour cultivation.
Conclusions: We achieved one gram per liter scale production of 4-coumaric acid. In addition, maximum titers of
150 mg/L of caffeic acid and 196 mg/L of ferulic acid were achieved. Phenylpropanoic acids, such as 4-coumaric
acid, caffeic acid, and ferulic acid, have a great potential for pharmaceutical applications and food ingredients. This
work forms a basis for further improvement in production and opens the possibility of microbial synthesis of more
complex plant secondary metabolites derived from phenylpropanoic acids.Background
Phenylpropanoic acids, such as 4-coumaric acid, caffeic
acid, and ferulic acid, are natural phenolic compounds
derived from the phenylpropanoid pathway [1]. Phenyl-
propanoic acids have attracted increasing attention for
their various pharmaceutical properties as well as a
valuable monomer for the production of liquid crystal
polymers, which can be used for electronic applications
[2-4]. Although these compounds are widely used in
human health care and industrial material, at present
they are mainly obtained by extraction from plants, and
extraction yields are low because most of these metabo-
lites accumulate at low levels in plant cells. Furthermore,* Correspondence: hongsoo@kribb.re.kr
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reproduction in any medium, provided the ortheir isolation from plant material, especially as pure
compounds, remains a challenge. Nowadays, large-scale
production of plant metabolites or precursors via micro-
bial approaches provides a promising alternative to chem-
ical synthesis and extraction from plant sources [5-7].
4-Coumaric acid, caffeic acid and ferulic acid are aro-
matic compounds containing a phenyl ring with a C3
side chain. These phenylpropanoic acids are the pivotal
intermediates of the plant phenylpropanoid pathway
starting from the deamination of tyrosine. Tyrosine
ammonia-lyase (TAL) catalyzes nonoxidative deamin-
ation of the primary amino acid tyrosine to 4-coumaric
acid (Figure 1). 4-Coumaric acid is converted into caffeic
acid by a hydroxylation step at the 3-position of the ben-
zyl ring. The 4-coumarate 3-hydroxylase (C3H) in plants
is composed mainly of cytochrome P450 dependent
monooxygenases. The purification and characterization
of this enzyme is quite challenging because of its in-
stability and membrane-bound property [8]. Recently, ad. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Figure 1 Proposed ferulic acid biosynthetic pathway starting with L-tyrosine. TAL, tyrosine ammonia lyase; Sam5, 4-coumarate hydroxylase;
COM, caffeic acid methyltransferase.
Kang et al. Microbial Cell Factories 2012, 11:153 Page 2 of 9
http://www.microbialcellfactories.com/content/11/1/153microbial C3H (Sam5) from the actinomycete Saccharo-
thrix espanaensis was reported and its function in
Escherichia coli was characterized [9]. 4-Coumaric acid
is easily converted into caffeic acid by E. coli containing
the Sam5 expression vector, which was also demon-
strated in our previous report [10]. Ferulic acid is
biosynthesized from caffeic acid by the enzyme caffeate
O-methyltransferase [10,11].
Like many other plant secondary metabolites, the pro-
duction yields of phenylpropanoic acids, notably caffeic
acid and ferulic acid, are still low because of the complex
and strict regulation of their biosynthesis in plant cells
[12,13]. Chemical and enzymatic methods have also been
used to produce those phenylpropanoic acid derivatives.
Recently, there has been increasing interest in microbial
production of phenylpropanoic acid derivatives by
reconstructing their biosynthetic pathways in microor-
ganisms. Sachan et al. reported the co-production of caf-
feic acid and p-hydroxybenzoic acid in Streptomyces
caeruleus by feeding 4-coumaric acid [14]. The conver-
sion of tyrosine to caffeic acid (50.2 mg/L) in E. coli was
achieved by the co-expression of the enzymes encoded
by the TAL from Rhodobacter and E. coli native 4-
hydroxyphenylacetate 3-hydroxylase (4HPA3H) [15]. We
also reported the production of ferulic acid in E. coli by
the sequential co-expression of the enzymes encoded
by the sam5 and tal genes from S. espanaensis and
an O-methyltransferase (COM) gene from Arabidopsis
thaliana [10].
Although previous studies have already made signifi-
cant gains in demonstrating the feasibility of microbial
production in E. coli, the biosynthetic efficiency is
greatly limited by the heterologous gene expression and/
or host cellular primary precursor productivities. Be-
cause tyrosine serves as the main precursor for phenyl-
propanoids, strains exhibiting an enhanced capacity for
its synthesis provide a natural platform for exploring the
potential of microbial phenylpropanoid production from
glucose [16,17]. In this study, we made an E. coli strain
capable of high-level tyrosine production containing
feedback-inhibition aroG and tyrA genes by modifying a
previously reported expression system [18,19]. The serial
artificial biosynthetic gene expression sets encoding
TAL, TAL & Sam5, and TAL & Sam5 & COM, graft intothe E. coli that is overproducing tyrosine (Figure 2). This
method led to the efficient production of serial phenyl-
propanoic acids, 4-coumaric acid, caffeic acid and ferulic
acid. The other three artificial expression sets containing
the codon-optimized tal gene tested the improvement
gene expression effect with respect to phenylpropanoic
acid production. In these systems, engineered E. coli
cultured in a growth medium, even through a simple fer-
mentation in minimal media without precursor supple-
mentation, produced the plant-specific 4-coumaric acid,
caffeic acid and ferulic acid to yield 974 mg/L, 150 mg/L,
and 196 mg/L, respectively. This report describes a con-
venient and efficient system for production of 4-coumaric
acid, caffeic acid and ferulic acid by microorganisms.
There is an obvious economic incentive to develop
strains capable of converting cheaper feedstocks to high
value compounds.Results and discussion
Comparison of in vivo activities of TAL and
codon-optimized TAL (opTAL)
TALs identified from various sources can catalyze the
direct formation of 4-coumaric acid from tyrosine. We
have already succeeded in synthesizing 4-coumaric acid
in E. coli from a simple medium without the addition of
tyrosine using TAL from S. espanaensis [10]. The pro-
duction of ferulic acid in E. coli was also achieved by the
co-expression of the enzymes encoded by the artificial
biosynthetic genes, tal, sam5, and com. However, the
production yield of ferulic acid using our previous strat-
egy was less than 10 mg/L [10]. Normally, actinomycete
genes are often difficult to express in E. coli. They might
contain codons and alterations of mRNA structural ele-
ments that are rarely used in E. coli [20,21]. In practice
with the pET system and other high-level E. coli expres-
sion systems, the presence of a small number of rare
codons often does not severely depress target protein
synthesis. To address this possibility, we tried to make
the ‘opTAL’ protein using the codon-optimized program
for overcoming the codon bias of the actinomycete gene
for enhanced protein expression in E. coli.
The genes encoding the two TALs were cloned and
expressed in E. coli using the plasmids pET-TAL and
T7 promoter; rbs RBS; T7 terminatorHis-tag;
Figure 2 Organization of the artificial gene clusters used for production of each phenylpropanoic acid in E. coli. Three heterologous
enzymes must be expressed in E. coli to mediate the synthesis of ferulic acid from tyrosine. All constructs contained the T7 promoter and the RBS
in front of each gene and the T7 terminator located in the rear of each gene. opTAL is a codon-optimized TAL enzyme. B, BamHI; Bg, BglII; H,
HindIII; P, PstI; Nd, NdeI.
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found in a large amount of TAL in both the insoluble
and soluble fractions, when cultured at 37°C (Additional
file 1: Figure S1). The transformant cells were cultured
at 26°C to avoid the formation of inclusion bodies from
the proteins. Even by culturing at 26°C, a considerable
amount of the 56 kDa TAL was still recovered in the
insoluble fraction (data not shown). To evaluate the
performance of the two TALs in E. coli, we assessed
4-coumaric acid production by culturing the recombin-
ant strains in M9 minimal media (with 15 g/L or 40 g/L
glucose) supplemented with 1 mM IPTG. Analysis of the
product after 36 hours showed that the production of
the 4-coumaric acid reached up to 144 ± 14 mg/L from
the pET-opTAL strain in a 15 g/L glucose medium,
which was 244% higher than the production from the
parental strain, pET-TAL (59 ± 7 mg/L) (Figure 3). The
codon-optimized TAL showed a marked effect in the
native tyrosine pathway of E. coli. On the other hand,
4-coumaric acid synthesis in a 40 g/L glucose medium
was 38 ± 2 mg/L (pET-TAL) and 129 ± 26 mg/L (pET-
opTAL). However, there was not a statistical significantly
difference between the titers for the 15 g/L and 40 g/L
glucose samples in media (α = 0.05) (Additional file 1:
Table S1). Therefore, the following experiments were
performed with an M9 minimal medium with 15 g/L
glucose.Effects of codon-optimized TAL on caffeic acid and ferulic
acid production
The functionality of this codon-optimized TAL (opTAL)
with Sam5 and Sam5 plus COM within E. coli was eval-
uated by monitoring the accumulation of caffeic acid
and ferulic acid in the culture supernatant. We have
already succeeded in synthesizing ferulic acid using the
artificial biosynthetic pathway containing the parental
TAL [10]. Thus, to obtain caffeic acid from a simple
medium without the addition of tyrosine, we made an
additional expression vector, pET-T5. In addition, we
constructed the same sequential expression vectors,
pET-opT5 and -opT5M, containing the codon-
optimized tal gene. The sequential expression vectors
were also equipped with their own T7 promoter, ribo-
some binding sites (RBS) and terminator to facilitate
strong and inducible expression within the E. coli, as in
the parental vectors (Figure 2).
To assess the caffeic acid biosynthesis, recombinant
E. coli strains with pET-T5 or pET-opT5 were cultured
in M9 minimal media supplemented with 15g/L glucose
as the sole carbon source (Table 1). Upon IPTG induc-
tion, the caffeic acid secreted in the culture media
was analyzed using high-performance liquid chroma-
tography (HPLC) after 36 hours. In this case, the synthe-
sis of caffeic acid in E. coli cells with pET-T5 reached




MM (+ glucose 15 g/L) MM (+ glucose 40 g/L)
pET-TAL 59 ± 7* 38 ± 2**
pET-opTAL 144 ± 14* 129 ± 26**
Figure 3 Comparison of TAL activity. Concentrations of 4-coumaric acid in strains with pET-TAL or pET-opTAL cultures in an M9 medium
containing glucose 15 g/L (Black bar and white bar) or 40 g/L (bo1d diagonal bar and thin diagonal bar). Each cultivation was done at least in
triplicate, and the standard deviations are shown. Error bars indicate standard errors of the means. The codon-optimized TAL activity and glucose
effect were compared by single-factor ANOVA (P < 0.05) using Microsoft Excel. Different stars codes (*, **) indicate significant differences (*, P =
9.44E-5; **, P = 1.62E-4).
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in E. coli cells with pET-opT5 did not improve. Rather,
the titer showed a pattern of decrease, even if the differ-
ence was not significant (P = 0.066). The low caffeic acid
productivity in comparison with the previous 4-coumaric
acid was perhaps due to poor expression of Sam5 pro-
teins coupled with high expression of codon-optimized
TAL protein. To address this possibility, the engineered
strains were tested for protein expression via SDS–PAGE
analysis (Additional file 1: Figure S2). However, a consid-
erable amount of the 59 kDa Sam5 protein was detected
as having opTAL protein (56 kDa), and the expressionTable 1 Production of caffeic acid and ferulic acid by










pET-T5 ND 42 ± 19a -
pET-opT5 26 ± 8 14 ± 2a -
pET-T5M ND ND 28 ± 10b
pET-opT5M ND ND 73 ± 15b
The engineered strains are cultured in an M9 medium containing glucose 15
g/L. Each batch cultivation was done at least in triplicate, and the standard
deviations are shown. Different letter codes (a and b) indicate significant
differences (a, P = 0.0664; b, P = 0.00226). The code ‘ND’ indicated that
something was not detected in our HPLC analysis.level of the parental TAL protein (different His-tagged
sequences; 57.4 kDa) showed a tendency to overlap with
the Sam5 protein itself (Additional file 1: Figure S2).
Thus, the low production of caffeic acids in the opTAL-
containing pathway (pET-opT5) was not a result merely
of poor protein expression, but may instead be related to
inherent deficiencies in enzyme activity. We suspected
that Sam5 activity may present a major bottleneck in
these strains and culture conditions.
On the other hand, ferulic acid synthesis in E. coli cells
harboring pET-T5M and pET-opT5M was 28 ± 10 mg/L
and 73 ± 15 mg/L, respectively, which was a 260% im-
provement in the codon-optimized TAL construct. An
unexpected improvement of the ferulic acid titer com-
pared with the caffeic acid titer in each codon-optimized
TAL construct was observed (14 mg/L up to 73 mg/L).
The reason for this titer improvement is still unknown,
but it is possible that the metabolic flow to ferulic acid
may be alleviating any restraint during accumulation of
caffeic acid in the cell.
Construction of tyrosine overproducer and improvement
of 4-coumaric acid production in the tyrosine
overproducing strain
In order to investigate the effect of intracellular tyro-
sine concentration on phenylpropanoid biosynthesis, the
Kang et al. Microbial Cell Factories 2012, 11:153 Page 5 of 9
http://www.microbialcellfactories.com/content/11/1/153production levels of 4-coumaric acid, caffeic acid and feru-
lic acid from the tyrosine overproducing strain were evalu-
ated. The biosynthesis of aromatic amino acids like
tyrosine was very tightly regulated by the concentration
of the final products. We first generated an E. coli
strain that disrupted the tyrR gene, the product of
which represses the expression genes involved in aro-
matic amino-acid biosynthesis [22]. In addition, the
feedback-inhibition-resistant (fbr) 3-deoxy-d-arabino-
heptulosonate-7-phosphate (DAHP) synthase (AroGfbr)
and chorismate mutase/prephenate dehydrogenase
(TyrAfbr) were overexpressed as previously reported by
Lütke-Eversloh and Stephanopoulos [18]. Thus, the
tyrosine over-producing E. coli strain contains an in-
frame deletion in tyrR and a plasmid (pAD-AG) expres-
sing the aroGfbr and tyrAfbr. The engineered E. coli cells
produced tyrosine in the M9 modified medium at a
yield of ~400 mg/L, when glucose was used as the car-
bon source (data not shown). By contrast, the E. coli
wild-type cells produced low quantities of tyrosine in
culture, which was not detectable in our experimental
conditions. The tyrosine production yield was comparable
to the E. coli T1 strain (346 mg/L) as previously reported
by Lütke-Eversloh and Stephanopoulos [18]. The E. coli T1
strain was made by introducing the constitutive promoter
PLtet−O1 for the expression of the aroG
fbr and tyrAfbr genes
in the low-copy-number (~5 copies/cell) plasmid pCL1920,
but our two fbr genes were cloned on the inducible T7
promoter of the medium-copy-number (20–30 copies/cell)
plasmid pACYCDuet-1.
Under the same experimental conditions as before,
strains overproducing tyrosine acquired a substantial
capacity for 4-coumaric acid, caffeic acid and ferulic acidpET-TAL pET-opTAL pET-T5





Figure 4 Comparison of 4-coumaric acid (A), caffeic acid (B) and ferul
overproducing E. coli strains. (A) Production of 4-coumaric acid with pET
pET-opT5; (C) Production of ferulic acid with pET-T5M and pET-opT5M. W, w
standard errors of the means. Different letters codes (a to c’) indicate signif
P = 4.3E-4; c, P = 1.67E-6; c’, P = 3.09E-7).synthesis (Figure 4 and Table 2). As seen in Figure 4A
and Table 2, tyrosine-overproducing E. coli (pAD-AG/
ΔtyrR) with pET-TAL and pET-opTAL produced more
than 974 ± 30 mg/L and 805 ± 41 mg/L of 4-coumaric
acid, respectively. The production increased by 1650%
and 559% over the parental strains, respectively. The
similar production between native and codon-optimized
TALs meant that the protein expression level was not a
critical factor for the 4-coumaric acid production affect-
ing the excessive tyrosine pool in our culture conditions.
Caffeic acid and ferulic acid production in the tyrosine
overproducing strain
The titers of caffeic acid did not significantly improve
(150 ± 8 mg/L and 40 ± 16 mg/L, respectively) in com-
parison to the 4-coumaric acid titers, despite 357% and
285% improvement over the parental strains (Table 2). As
previously mentioned, the same artificial pathways (pET-
T5 and pET-opT5) produced 42 mg/L and 14 mg/L of
caffeic acid in the native tyrosine pathway of E. coli
(Table 1). The titer of caffeic acid (150 ± 8 mg/L) with
TAL (pET-T5) was higher than the titer (50 mg/L) of the
pathway using 4-hydroxyphenylacetate 3-hydroxylase and
TAL as recently reported by Lin et al. [15]. However,
the caffeic acid titers with codon-optimized TAL and
Sam5 co-expression reached only 4.9% of that of the
4-coumaric acid seen with the codon-optimized TAL
expression alone (40 mg/L vs. 805 mg/L). In addition,
the tyrosine overproducers containing pET-T5 and
-opT5 also accumulated 307 mg/L and 511 mg/L of
4-coumaric acid, respectively (Table 2), and this result
meant that the TAL enzymes operated normally, but that
Sam5 did not convert 4-coumaric acid to caffeic acidpET-opT5 pET-T5M pET-opT5M





ic acid (C) between wild-type and engineered tyrosine
-TAL and pET-opTAL; (B) Production of caffeic acid with pET-T5 and
ild-type E. coli; T, tyrosine overproducing E. coli. Error bars indicate
icant differences (a, P = 2.06E-7; a’, P = 2.71E-12; b, P = 8.48E-4; b’,
Table 2 Production of caffeic acid and ferulic acid by










pET-TAL 974 ± 30a - -
pET-opTAL 805 ± 41a - -
pET-T5 307 ± 8 150 ± 8b -
pET-opT5 511 ± 69 40 ± 16b -
pET-T5M 113 ± 12 22 ± 3 196 ± 26c
pET-opT5M 150 ± 17 46 ± 7 187 ± 12c
Each batch cultivation was done at least in triplicate, and the standard
deviations are shown. Different letter codes (a to c) indicate significant
differences (a, P = 0.0216; b, P = 7.17E-07; c, P = 0.5176).
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to be a somewhat low titer (40 ± 16 mg/L), the pre-
sence of any significant 4-coumaric acid accumulation
(511 ± 69 mg/L) suggested that this discrepancy may be
related to enhanced protein synthesis from the codon-
optimized tal gene rather than 4-coumaric acid produc-
tion and consumption.
On the other hand, ferulic acid synthesis levels in
tyrosine-overproducing E. coli cells with pET-T5M
and pET-opT5M were 196 ± 26 mg/L and 187 ± 12
mg/L, respectively. At the same time, the accumula-
tion of 4-coumaric acid and caffeic acid also was iden-
tified at an expected amount (113 and 22 mg/L and
150 and 46 mg/L, respectively). As was the case for the
previous result in wild-type E. coli, the titers of ferulic
acid also show an increase over caffeic acid in the
tyrosine-overproducing strain.
Conclusions
We successfully established artificial biosynthetic path-
ways for precursor phenolic acids of phenylpropanoid
and constructed E. coli strains for the de novo produc-
tion of 4-coumaric, caffeic, and ferulic acids. The TALs
from S. espanaensis and a codon-optimized synthetic
gene expressed the native tyrosine pathway of E. coli and
produced 59 ± 7 mg/L and 144 ± 14 mg/L of 4-coumaric
acid from glucose sources (Figure 3). Further improve-
ment of 4-coumaric acid production was accomplished
by alleviating feedback inhibition and deregulating aro-
matic amino acids flux into tyrosine biosynthesis. Finally,
the titers of 4-coumaric acid reached 974 ± 30 mg/L and
805 ± 41 mg/L in shake flasks after 36-hour cultivation
(Table 2). We confirmed that codon optimization of the
tal gene had a good effect on de novo production of 4-
coumaric acid in a native tyrosine pathway, but the effect
was offset by a sufficient tyrosine supply. More notably,
this augmented precursor pool had a direct impact on
4-coumaric acid production, which increased 6.7-fold to
yield a final titer of 974 ± 30 mg/L.An artificial pathway leading from tyrosine to caffeic
acid was then constructed and introduced into two kinds
of E. coli. The caffeic acid levels increased to 150 mg/L
and 40 mg/L in the tyrosine overproducer from just
42 mg/l and 14 mg/L in the native strain, respectively.
The ferulic acid levels increased to 187 mg/L from
40 mg/L of caffeic acid in the tyrosine overproducer and
to 73 mg/L from just 14 mg/L in the native strain.
As seen in Table 1, expressing all three genes that
involved the codon-optimized tal gene led to a 2.6-fold
increase in ferulic acid production comprising with
native TAL expression in the parental strain (28 mg/L
up to 73 mg/L). Similarly, the titer of 4-coumaric acid
also increased 2.4-fold (59 mg/L up to 144 mg/L) in the
same experimental conditions (Figure 3). However, in
the tyrosine overproducing strain, the 4-coumaric acid
(805 mg/L vs. 974 mg/L) and ferulic acid (187 mg/L vs.
196 mg/L) titers were similar to native and codon-
optimized constructs. Therefore, we suggest that at least
in our system the titer of an artificial biosynthetic path-
way is more dependent on a higher metabolite (precur-
sors and intermediates) concentration and/or flux than
on each enzyme’s excess expression rate.
Finally, we achieved almost one gram per liter scale pro-
duction of 4-coumaric acid. Maximum titers of 150 mg/L
of caffeic acid and 196 mg/L of ferulic acid were achieved.
Phenylpropanoic acids, such as 4-coumaric acid, caffeic
acid, and ferulic acid, have great potential for pharmaceut-
ical applications and food ingredients.
Methods
Bacterial strains, plasmids, and chemicals
E. coli DH5α and E. coli C41 (DE3) [23] were used for
general DNA manipulation and expression of biosyn-
thetic genes, respectively. A pCR-TOPO vector (Invitro-
gen, Carlsbad, CA) was used for polymerase chain
reaction (PCR) cloning. pET-28a(+) was purchased from
Novagen (San Diego, CA). L-Tyrosine, 4-coumaric acid,
caffeic acid, ferulic acid, and IPTG were purchased from
Sigma-Aldrich (St. Louis, MO). Restriction enzymes
(NEB), ExTaq (Takara Biochemicals Inc.), pfu (Solgent,
Korea), an AccuPower Ligation kit (Bioneer, Korea), and
a Quick & Easy E. coli gene deletion kit (Gene Bridges,
German) were used according to the instructions pro-
vided by the manufacturers.
Codon optimization and synthesis of TAL, AroGfbr, and
TyrAfbr
Codon optimization and synthesis of tal from S. espa-
naensis was performed with the GeneGPS™ program
(DNA2.0). From here forward, synthetic genes/proteins
are denoted by superscript “op” DNA sequences. Both
AroG and TyrA feedback-inhibition resistance (fbr) deriva-
tives were used to overcome the end-product inhibition of
Table 3 Plasmids and strains used in this study
Plasmid or strain Relevant Characteristics Source
Plasmids
pET-28a(+) f1 ori, T7 promoter, KanR Novagen
pET-22b(+) f1 ori, T7 promoter AmpR Novagen
pET-TAL pET-28a(+) carrying TAL from Saccharothrix espanaensis Choi.et al. [10]
pET-opTAL pET-28a(+) carrying codon-optimized S. espanaensis TAL This study
pET-Sam5 pET-28a(+) carrying Sam5 from S. espanaensis Choi.et al. [10]
pET-COM pET-28a(+) carrying COM from Arabidopsis thaliana Choi.et al. [10]
pET-T5 pET-28a(+) carrying S. espanaensis TAL and Sam5 This study
pET-opT5 pET-28a(+) carrying codon-optimized TAL and S. espanaensis Sam 5 This study
pET-T5M pET-28a(+) carrying S. espanaensis TAL, S. espanaensis Sam5, and A. thaliana COM Choi.et al. [10]
pET-opT5M pET-28a(+) carrying codon-optimized TAL, S. espanaensis Sam5, and A. thaliana COM This study
pACYCDuet-1 p15A ori, double T7 promoter, CmR Novagen
pET28-tyrA* pET-28a(+) carrying codon-optimized tyrAfbr This study
pET22-aroG* pET-22b(+) carrying codon-optimized aroGfbr This study
pAD-AG pACYDuet-1 carrying codon-optimized tyrAfbr and aroGfbr This study
Strains
E. coli DH5a cloning host Invitrogen
E. coli C41(DE3) derivative strain of E. coli BL21(DE3) Miroux B & Walker JE [23]
ΔtyrR tryR gene in-frame deletion mutant of E. coli C41(DE3) This study
pAD-AG/ΔtyrR E. coli C41(DE3) ΔtryR :: pAD-AG; tyrosine overproducing strain This study
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146-Asn substitution [24], and the TyrAfbr enzyme com-
prised a Met-53-Ile in the chorismate mutase domain and
Ala-354-Val substitution in the prephenate dehydrogenase
domain [19]. Codon optimization and synthesis of the
aroGfbr and tyrAfbr genes were also performed by DNA2.0.Heterologous pathway construction and assembly
A list of plasmids and strains used in this study can be
found in Table 3. The plasmids were assembled by a ser-
ial stepwise cloning process as previously reported [10].
Briefly, the four genes (tal, optal, sam5, and com) were
independently cloned into pET-28a(+). To construct an
expression vector containing the three genes that were
each under the control of an independent T7 promoter,
we amplified the 1.76-kb DNA fragment containing
the TAL coding region using pET-TAL as a template
with primer TAL-N and CPac (the sequence is located
downstream of the T7 terminator region of the pET
vector and contains the designed PacI site; Additional
file 1: Table S2). Using the pET-Sam5 as a template, the
2.54-kb DNA fragment containing the sam5 coding
region was PCR-amplified with primer NPac (the
sequence was located upstream of the T7 promoter
region of the pET vector and contained the designed
PacI site; Additional file 1: Table S2) and CPac. The
amplified fragments were digested with each restriction
enzyme and cloned between PacI- and HindIII-digestedpET-28a(+) by a three-fragment ligation, resulting in pET-
T5. To construct a pET-T5M vector, the 2.54-kb DNA
fragment containing the sam5 coding region was PCR-
amplified with primer NPac (the sequence was located up-
stream of the T7 promoter region of the pET vector and
contained the designed PacI site; Additional file 1: Table
S2) and CPac. In addition, the 1.88-kb DNA fragment con-
taining the COM coding region was PCR-amplified using
pET-COM as a template with primer NPac and COM-R.
The amplified fragments were digested with each of the re-
striction enzymes and cloned between BamHI- and Hin-
dIII-digested pET-28a(+) by a four-fragment ligation,
resulting in pET-T5M. The pET-opTAL, pET-opT5, and
pET-opT5M vectors were constructed the same way as
the previous vectors, pET-TAL, pET-T5, and pET-T5M, re-
spectively. Gene sequences and orientations were verified
by sequencing after each round of cloning.In-frame deletion of the tyrR gene
The genetic design of the L-tyrosine overproducing
strain was followed as previously described by Lütke-
Eversloh and Stephanopoulos [18]. The in-frame dele-
tion of tyrR, a repressor gene of aromatic amino acid
biosynthesis, was constructed by RED/ET recombination
with a Quick & Easy E. coli Gene deletion kit (Gene
Bridges) using the manufacturer’s protocols. The PCR
recombination product was generated using the FRT-
PGK-gb2-neo-FRT fragment as a template for the FRT-
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tyr-Rf (50-GTCATATCAT CATATTAAT TGTTCTT-
TTT TCAGGTGAAG GTTCCCATGC GTAATTAACC
CTCACTAAAG GGCG-30) and tyr-Rr (50-ATCAGG-
CATA TTCGCGCTTA CTCTTCGTTC TTCTTCTGAC
TCAGACCATA TAATACGACT CACTATAGGG CTC-30).
The kanamycin selection marker was removed from the
chromosome by transforming the cells with an FLP recom-
binase expression plasmid, 706-FLP (Gene Bridges).
The clones growing on the kanamycin plate still con-
tained the selection marker cassette, while all other
clones containing in-frame deletion lost the selection
marker. The in-frame deletion mutant (ΔtyrR) was verified
through PCR using the following primers: tyr-v1 (50-
AACCT CGCCT CGGGG ATTTC −30) and tyr-v2 (50-
AGCGC GTGCC GTTGT GGTTA −30). The PCR product
was sequenced and verified.
Construction of L-tyrosine overproducing strain
The L-tyrosine over-producing E. coli strain was
achieved by overexpression of aroGfbr and tyrAfbr genes
in the in-frame deletion ΔtyrR mutant. To elevate the
expression levels of the aroGfbr and tyrAfbr genes, the
RBS and the T7 promoter were positioned in front of
both genes. A synthetic aroGfbr DNA fragment (from
DNA2.0) was digested with restriction enzymes NdeI-
and HindIII, and the appropriate fragments were ligated
into pET-22b(+) to form pET22-aroG* (Table 3). The
pET28-tyrA*, which contained a codon-optimized 1.1-kb
tyrAfbr coding region, was digested with restriction
enzymes and cloned between NcoI- and HindIII restric-
tion enzyme sites of MCS1 of pACYCDuet-1, resulting
in pAD-tyrA*. Then, the 1.1-kb DNA fragment contain-
ing the aroGfbr coding region of the pET22-aroG* was
digested with restriction enzymes NdeI and XhoI, includ-
ing the HindIII site of the stop codon, and cloned
between the NdeI- and XhoI restriction enzyme sites of
MCS2 of pAD-tyrA*, resulting in pAD-AG (Table 3). The
L-tyrosine over-producing E. coli strain (pAD-AG/ΔtyrR)
was achieved by a ΔtyrR mutant carrying pAD-AG.
Culture conditions for production
Recombinant E. coli C41 (DE3) strains harboring plasmids
were precultured overnight at 37°C in a Luria–Bertani
(LB) medium containing 50 μg/mL kanamycin. The over-
night culture was inoculated (1.5%) into a fresh LB
medium supplemented with the same concentration of
kanamycin. The culture was grown at 37°C to an optical
density of 600 nm (OD600) of 0.6. IPTG was added to the
final concentration of 1 mM, and the culture was incu-
bated for 5 hours. The cells were harvested by centrifuga-
tion, suspended, and incubated at 26°C for 36 hours in a
modified M9 medium (M9 medium supplemented with
15 g/L glucose, 25 g/L CaCO3, appropriate antibiotics(50 μg/mL kanamycin for maintenance of pET-derived
plasmids and 34 μg/mL chloramphenicol for pACYC-
derived plasmid (pAD-AG)), and 1 mM IPTG) [10,25].
The samples were collected after 36 hours and analyzed by
HPLC.Detection and quantification of the products
For the quantification of L-tyrosine, 4-coumaric acid,
caffeic acid, and ferulic acid, 1 mL of cell-free culture
supernatants were filtered through 0.2 μm Cellulose
membrane syringe filters (Sartorius) and used for HPLC
analysis with a Dionex Separations module connected
with a Photodiode Array detector (Dionex) set. The
compounds were separated by elution with an
acetonitrile-water gradient (water containing 0.05% tri-
fluoroacetic acid (TFA)). The L-tyrosine was separated
on a YMC C18 column (150 × 4.6 mm, 4 μm). The fol-
lowing gradient was used at a flow rate of 1 mL/min: 5%
to 80% acetonitrile for 25 min, 80% to 100% acetonitrile
for 3 min, 100% acetonitrile for 3 min, 100% to 5%
acetonitrile for 3 min, and 5% acetonitrile for an add-
itional 3 min. The 4-coumaric acid was separated on a
YMC C18 column. The following gradient was used at a
flow rate of 1 mL/min: 20% to 60% acetonitrile for
25 min, 60% to 100% acetonitrile for 1 min, 100% aceto-
nitrile for 5 min, 100% to 20% acetonitrile for 2 min, and
20% acetonitrile for an additional 5 min. The caffeic acid
was separated on a YMC C18 column. The following
gradient was used at a flow rate of 1 mL/min: 15% aceto-
nitrile for 5 min, 15% to 60% acetonitrile for 15 min,
60% to 100% acetonitrile for 5 min, 100% acetonitrile for
5 min, 100% to 15% acetonitrile for 2 min, and 15%
acetonitrile for an additional 5 min. The ferulic acid was
separated on a SunFire™ C18 column (250 × 4.6 mm,
5 μm; Waters, USA). The following gradient was used at
a flow rate of 1 mL/min: 20% to 25% acetonitrile for
15 min, 25% to 100% acetonitrile for 5 min, 100% aceto-
nitrile for 5 min, 100% to 20% acetonitrile for 5 min, and
20% acetonitrile for an additional 5 min. Quantification
for the four above-mentioned compounds was based on
the peak areas of absorbance at 250 nm (L-tyrosine),
300 nm (4-coumaric acid) and 320 nm (caffeic acid and
ferulic acid). The concentrations were determined
through the use of the corresponding chemical standards
(Sigma).
The data shown in this study were generated from
triplicate independent experiments. The titers of each
production were compared by single-factor ANOVA
(P < 0.05) using the single-factor ANOVA tool. The
Tukey honestly significant difference (HSD) test was
used to determine the significance of differences be-
tween group means. The data were analyzed using
Microsoft Office Excel 2007 and IBM SPSS Statistics.
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Additional file 1: Figure S1. Comparison of the TAL protein expression
of pET-opTAL and pET-TAL in E. coli. Lane 1: E. coli transformation
containing pET-opTAL expression vector lysate after IPTG induction; Lane
2: lysate before induction; Lane 3: E. coli transformation containing pET-
TAL expression vector lysate after IPTG induction; Lane 4: lysate before
induction. Figure S2. SDS-PAGE analysis of co-expression of TAL and
Sam5 enzymes in E. coli. Lane 1: E. coli transformation containing pET-
opT5 expression vector lysate before IPTG induction; Lane 2: lysate after
induction; Lane 3: E. coli transformation containing pET-T5 expression
vector lysate before IPTG induction; Lane 4: lysate after induction. Sam5
protein is 59 kDa, TAL protein from pET-opT5 expression vector is 56 kDa,
TAL protein from pET-T5 expression vector is 57.4 kDa. The difference in
the TAL proteins comes from the length of the His-tagged peptide
sequences. Table S1. The results of the Tukey test for the data from
Figure 3. Table S2. Oligo nucleotide primers used in this study.Competing interests
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